Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 353

1.

Pregnancy, time to pregnancy and obstetric outcomes among female childhood cancer survivors: results of the DCOG LATER-VEVO study.

van Dijk M, van Leeuwen FE, Overbeek A, Lambalk CB, van den Heuvel-Eibrink MM, van Dorp W, Tissing WJ, Kremer LC, Loonen JJ, Versluys B, Bresters D, Ronckers CM, van der Pal HJ, Beerendonk CCM, Kaspers GJL, van Dulmen-den Broeder E, van den Berg MH.

J Cancer Res Clin Oncol. 2020 Mar 27. doi: 10.1007/s00432-020-03193-y. [Epub ahead of print]

PMID:
32221745
2.

Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation.

Sciarrillo R, Wojtuszkiewicz A, Kooi IE, Leon LG, Sonneveld E, Kuiper RP, Jansen G, Giovannetti E, Kaspers GJL, Cloos J.

Cancers (Basel). 2020 Mar 19;12(3). pii: E723. doi: 10.3390/cancers12030723.

3.

Psychometric properties of the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance and Sleep-Related Impairment item banks in adolescents.

van Kooten JAMC, Terwee CB, Luijten MAJ, Steur LMH, Pillen S, Wolters NGJ, Kaspers GJL, van Litsenburg RRL.

J Sleep Res. 2020 Mar 16:e13029. doi: 10.1111/jsr.13029. [Epub ahead of print]

PMID:
32180280
4.

Combined therapy of AXL and HDAC inhibition reverses mesenchymal transition in diffuse intrinsic pontine glioma.

Meel MH, de Gooijer MC, Metselaar DS, Sewing ACP, Zwaan K, Waranecki P, Breur M, Buil LCM, Lagerweij T, Wedekind LE, Twisk JWR, Koster J, Hashizume R, Raabe EH, Montero-Carcaboso A, Bugiani M, Phoenix TN, van Tellingen O, van Vuurden DG, Kaspers GJL, Hulleman E.

Clin Cancer Res. 2020 Mar 12. pii: clincanres.3538.2019. doi: 10.1158/1078-0432.CCR-19-3538. [Epub ahead of print]

PMID:
32165429
5.

Actigraphic estimates of sleep and the sleep-wake rhythm, and 6-sulfatoxymelatonin levels in healthy Dutch children.

Rensen N, Steur LMH, Wijnen N, van Someren EJW, Kaspers GJL, van Litsenburg RRL.

Chronobiol Int. 2020 Mar 4:1-13. doi: 10.1080/07420528.2020.1727916. [Epub ahead of print]

PMID:
32126835
6.

High prevalence of parent-reported sleep problems in pediatric patients with acute lymphoblastic leukemia after induction therapy.

Steur LMH, Grootenhuis MA, Van Someren EJW, Van Eijkelenburg NKA, Van der Sluis IM, Dors N, Van den Bos C, Tissing WJE, Kaspers GJL, Van Litsenburg RRL.

Pediatr Blood Cancer. 2020 Apr;67(4):e28165. doi: 10.1002/pbc.28165. Epub 2020 Jan 15.

PMID:
31944548
7.

Sleep-wake rhythm disruption is associated with cancer-related fatigue in pediatric acute lymphoblastic leukemia.

Steur LMH, Kaspers GJL, Van Someren EJW, Van Eijkelenburg NKA, Van der Sluis IM, Dors N, Van den Bos C, Tissing WJE, Grootenhuis MA, Van Litsenburg RRL.

Sleep. 2019 Dec 31. pii: zsz320. doi: 10.1093/sleep/zsz320. [Epub ahead of print]

PMID:
31889198
8.

Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia: Recent experiences of the Dutch Childhood Oncology Group.

Klein K, van Litsenburg RRL, de Haas V, Dors N, van den Heuvel-Eibrink MM, Knops RRG, Tissing WJE, Versluys BA, Zwaan CM, Kaspers GJL.

Pediatr Blood Cancer. 2020 Apr;67(4):e28099. doi: 10.1002/pbc.28099. Epub 2019 Dec 23.

PMID:
31872548
9.

Determinants of health-related quality of life proxy rating disagreement between caregivers of children with cancer.

Rensen N, Steur LMH, Schepers SA, Merks JHM, Moll AC, Kaspers GJL, Van Litsenburg RRL, Grootenhuis MA.

Qual Life Res. 2019 Dec 9. doi: 10.1007/s11136-019-02365-9. [Epub ahead of print]

PMID:
31820207
10.

Population Pharmacokinetics and -Dynamics of Ciprofloxacin Prophylaxis in Pediatric ALL Patients.

Sassen SDT, Mathôt RAA, Pieters R, van Westreenen M, de Haas V, Kaspers GJL, van den Bos C, Tissing WJE, Te Loo DMWW, Bierings MB, van der Sluis IM, Zwaan CM.

Clin Infect Dis. 2019 Dec 2. pii: ciz1163. doi: 10.1093/cid/ciz1163. [Epub ahead of print]

PMID:
31790556
11.

SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource-limited settings.

Bansal D, Davidson A, Supriyadi E, Njuguna F, Ribeiro RC, Kaspers GJL.

Pediatr Blood Cancer. 2019 Nov 27:e28087. doi: 10.1002/pbc.28087. [Epub ahead of print]

PMID:
31774234
12.

Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin.

Metselaar DS, Meel MH, Benedict B, Waranecki P, Koster J, Kaspers GJL, Hulleman E.

EBioMedicine. 2019 Dec;50:81-92. doi: 10.1016/j.ebiom.2019.10.062. Epub 2019 Nov 14.

13.

Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score.

Schouten SM, van de Velde ME, Kaspers GJL, Mokkink LB, van der Sluis IM, van den Bos C, Hartman A, Abbink FCH, van den Berg MH.

Support Care Cancer. 2019 Nov 16. doi: 10.1007/s00520-019-05106-3. [Epub ahead of print]

PMID:
31732853
14.

Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemia.

Løhmann DJA, Asdahl PH, Abrahamsson J, Ha SY, Jónsson ÓG, Kaspers GJL, Koskenvuo M, Lausen B, De Moerloose B, Palle J, Zeller B, Sung L, Hasle H.

Cancer Med. 2019 Nov;8(15):6634-6643. doi: 10.1002/cam4.2554. Epub 2019 Sep 18.

15.

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

El-Khouly FE, Veldhuijzen van Zanten SEM, Santa-Maria Lopez V, Hendrikse NH, Kaspers GJL, Loizos G, Sumerauer D, Nysom K, Pruunsild K, Pentikainen V, Thorarinsdottir HK, Rutkauskiene G, Calvagna V, Drogosiewicz M, Dragomir M, Deak L, Kitanovski L, von Bueren AO, Kebudi R, Slavc I, Jacobs S, Jadrijevic-Cvrlje F, Entz-Werle N, Grill J, Kattamis A, Hauser P, Pears J, Biassoni V, Massimino M, Lopez Aguilar E, Torsvik IK, Joao Gil-da-Costa M, Kumirova E, Cruz-Martinez O, Holm S, Bailey S, Hayden T, Thomale UW, Janssens GOR, Kramm CM, van Vuurden DG.

J Neurooncol. 2019 Oct;145(1):177-184. doi: 10.1007/s11060-019-03287-9. Epub 2019 Sep 14.

16.

MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors.

Meel MH, Guillén Navarro M, de Gooijer MC, Metselaar DS, Waranecki P, Breur M, Lagerweij T, Wedekind LE, Koster J, van de Wetering MD, Schouten-van Meeteren N, Aronica E, van Tellingen O, Bugiani M, Phoenix TN, Kaspers GJL, Hulleman E.

Neuro Oncol. 2020 Jan 11;22(1):58-69. doi: 10.1093/neuonc/noz151.

17.

Development of an evidence-based decision aid on complementary and alternative medicine (CAM) and pain for parents of children with cancer.

Jong MC, Boers I, van Wietmarschen H, Busch M, Naafs MC, Kaspers GJL, Tissing WJE.

Support Care Cancer. 2020 May;28(5):2415-2429. doi: 10.1007/s00520-019-05058-8. Epub 2019 Sep 6.

18.

Concurrence of sleep problems and distress: prevalence and determinants in parents of children with cancer.

Rensen N, Steur LMH, Schepers SA, Merks JHM, Moll AC, Grootenhuis MA, Kaspers GJL, van Litsenburg RRL.

Eur J Psychotraumatol. 2019 Jul 22;10(1):1639312. doi: 10.1080/20008198.2019.1639312. eCollection 2019.

19.

Longitudinal development of cancer-related fatigue and physical activity in childhood cancer patients.

Van Dijk-Lokkart EM, Steur LMH, Braam KI, Veening MA, Huisman J, Takken T, Bierings M, Merks JH, Van den Heuvel-Eibrink MM, Kaspers GJL, Van Dulmen-den Broeder E, Van Litsenburg RRL.

Pediatr Blood Cancer. 2019 Dec;66(12):e27949. doi: 10.1002/pbc.27949. Epub 2019 Aug 22.

PMID:
31436372
20.

A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.

Janssen JM, Dorlo TPC, Niewerth D, Wilhelm AJ, Zwaan CM, Beijnen JH, Attarbaschi A, Baruchel A, Fagioli F, Klingebiel T, De Moerloose B, Palumbo G, von Stackelberg A, Kaspers GJL, Huitema ADR.

Clin Pharmacokinet. 2020 Feb;59(2):207-216. doi: 10.1007/s40262-019-00803-y.

PMID:
31313068
21.

Preclinical therapeutic targets in diffuse midline glioma.

Meel MH, Kaspers GJL, Hulleman E.

Drug Resist Updat. 2019 May;44:15-25. doi: 10.1016/j.drup.2019.06.001. Epub 2019 Jun 7. Review.

22.

Influence of health insurance status on childhood cancer treatment outcomes in Kenya.

Olbara G, Martijn HA, Njuguna F, Langat S, Martin S, Skiles J, Vik T, Kaspers GJL, Mostert S.

Support Care Cancer. 2020 Feb;28(2):917-924. doi: 10.1007/s00520-019-04859-1. Epub 2019 Jun 7.

PMID:
31172285
23.

Acute myeloid leukaemia niche regulates response to L-asparaginase.

Kaspers GJL.

Br J Haematol. 2019 Aug;186(3):397-399. doi: 10.1111/bjh.15924. Epub 2019 Apr 24. No abstract available.

24.

Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.

Moshaver B, Wouters RF, Kelder A, Ossenkoppele GJ, Westra GAH, Kwidama Z, Rutten AR, Kaspers GJL, Zweegman S, Cloos J, Schuurhuis GJ.

Leuk Res. 2019 Jun;81:27-34. doi: 10.1016/j.leukres.2019.04.004. Epub 2019 Apr 9.

PMID:
31002948
25.

Gender-specific differences in parental health-related quality of life in childhood cancer.

Rensen N, Steur LM, Schepers SA, Merks JH, Moll AC, Kaspers GJ, Grootenhuis MA, van Litsenburg RR.

Pediatr Blood Cancer. 2019 Jul;66(7):e27728. doi: 10.1002/pbc.27728. Epub 2019 Mar 27.

PMID:
30916456
26.

Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.

Jaramillo AC, Cloos J, Lemos C, Stam RW, Kaspers GJL, Jansen G, Peters GJ.

Leuk Res. 2019 Apr;79:45-51. doi: 10.1016/j.leukres.2019.02.008. Epub 2019 Feb 23.

PMID:
30849662
27.

Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01.

Løhmann DJA, Asdahl PH, Abrahamsson J, Ha SY, Jónsson ÓG, Kaspers GJL, Koskenvuo M, Lausen B, De Moerloose B, Palle J, Zeller B, Hasle H.

Pediatr Blood Cancer. 2019 Jun;66(6):e27701. doi: 10.1002/pbc.27701. Epub 2019 Mar 7.

PMID:
30848067
28.

Uterine function, pregnancy complications, and pregnancy outcomes among female childhood cancer survivors.

van de Loo LEXM, van den Berg MH, Overbeek A, van Dijk M, Damen L, Lambalk CB, Ronckers CM, van den Heuvel-Eibrink MM, Kremer LCM, van der Pal HJ, Laven JSE, Tissing WJE, Loonen JJ, Versluys B, Bresters D, Kaspers GJL, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER-VEVO Study Group.

Fertil Steril. 2019 Feb;111(2):372-380. doi: 10.1016/j.fertnstert.2018.10.016.

PMID:
30691634
29.

Psychometric properties and norm scores of the sleep self report in Dutch children.

Steur LMH, Grootenhuis MA, Terwee CB, Pillen S, Wolters NGJ, Kaspers GJL, van Litsenburg RRL.

Health Qual Life Outcomes. 2019 Jan 16;17(1):15. doi: 10.1186/s12955-018-1073-x.

30.

An efficient method for the transduction of primary pediatric glioma neurospheres.

Meel MH, Metselaar DS, Waranecki P, Kaspers GJL, Hulleman E.

MethodsX. 2018 Feb 27;5:173-183. doi: 10.1016/j.mex.2018.02.006. eCollection 2018.

31.

Effects of a combined physical and psychosocial training for children with cancer: a randomized controlled trial.

Braam KI, van Dijk-Lokkart EM, Kaspers GJL, Takken T, Huisman J, Buffart LM, Bierings MB, Merks JHM, van den Heuvel-Eibrink MM, Veening MA, van Dulmen-den Broeder E.

BMC Cancer. 2018 Dec 27;18(1):1289. doi: 10.1186/s12885-018-5181-0.

32.

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.

Sciarrillo R, Wojtuszkiewicz A, El Hassouni B, Funel N, Gandellini P, Lagerweij T, Buonamici S, Blijlevens M, Zeeuw van der Laan EA, Zaffaroni N, Deraco M, Kusamura S, Würdinger T, Peters GJ, Molthoff CFM, Jansen G, Kaspers GJL, Cloos J, Giovannetti E.

EBioMedicine. 2019 Jan;39:215-225. doi: 10.1016/j.ebiom.2018.12.025. Epub 2018 Dec 20.

33.

Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality.

Reedijk AMJ, Klein K, Coebergh JWW, Kremer LC, Dinmohamed AG, de Haas V, Versluijs AB, Ossenkoppele GJ, Beverloo HB, Pieters R, Zwaan CM, Kaspers GJL, Karim-Kos HE.

Leukemia. 2019 Jun;33(6):1349-1359. doi: 10.1038/s41375-018-0314-7. Epub 2018 Dec 19.

PMID:
30568171
34.

A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia.

Kloos RQH, van Litsenburg RRL, Wolf S, Wismans L, Kaspers GJL, Uyl-de Groot CA, Pieters R, van der Sluis IM.

Pediatr Blood Cancer. 2019 Jan;66(1):e27458. doi: 10.1002/pbc.27458. Epub 2018 Sep 23.

PMID:
30246496
35.

Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfürt-Münster (I-BFM) study group.

Klein K, Hasle H, Abrahamsson J, De Moerloose B, Kaspers GJL.

Br J Haematol. 2018 Oct;183(1):87-95. doi: 10.1111/bjh.15499. Epub 2018 Aug 3.

PMID:
30074239
36.

MELK Inhibition in Diffuse Intrinsic Pontine Glioma.

Meel MH, de Gooijer MC, Guillén Navarro M, Waranecki P, Breur M, Buil LCM, Wedekind LE, Twisk JWR, Koster J, Hashizume R, Raabe EH, Montero Carcaboso A, Bugiani M, van Tellingen O, van Vuurden DG, Kaspers GJL, Hulleman E.

Clin Cancer Res. 2018 Nov 15;24(22):5645-5657. doi: 10.1158/1078-0432.CCR-18-0924. Epub 2018 Jul 30.

37.

Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.

van den Berg MH, Overbeek A, Lambalk CB, Kaspers GJL, Bresters D, van den Heuvel-Eibrink MM, Kremer LC, Loonen JJ, van der Pal HJ, Ronckers CM, Tissing WJE, Versluys AB, van der Heiden-van der Loo M, Heijboer AC, Hauptmann M, Twisk JWR, Laven JSE, Beerendonk CCM, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER-VEVO study group.

Hum Reprod. 2018 Aug 1;33(8):1474-1488. doi: 10.1093/humrep/dey229.

PMID:
29982673
38.

Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL.

Testi AM, Pession A, Diverio D, Grimwade D, Gibson B, de Azevedo AC, Moran L, Leverger G, Elitzur S, Hasle H, van der Werff ten Bosch J, Smith O, De Rosa M, Piciocchi A, Lo Coco F, Foà R, Locatelli F, Kaspers GJL.

Blood. 2018 Jul 26;132(4):405-412. doi: 10.1182/blood-2018-03-836528. Epub 2018 May 22.

PMID:
29789356
39.

Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia.

Løhmann DJA, Asdahl PH, Abrahamsson J, Ha SY, Jónsson ÓG, Kaspers GJL, Koskenvuo M, Lausen B, De Moerloose B, Palle J, Zeller B, Hasle H.

Pediatr Blood Cancer. 2018 Sep;65(9):e27231. doi: 10.1002/pbc.27231. Epub 2018 May 21.

PMID:
29781563
40.

Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study.

van Eijkelenburg NKA, Rasche M, Ghazaly E, Dworzak MN, Klingebiel T, Rossig C, Leverger G, Stary J, De Bont ESJM, Chitu DA, Bertrand Y, Brethon B, Strahm B, van der Sluis IM, Kaspers GJL, Reinhardt D, Zwaan CM.

Haematologica. 2018 Sep;103(9):1484-1492. doi: 10.3324/haematol.2017.187153. Epub 2018 May 17.

41.

Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.

Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, Carret AS, Escorza NY, Hassall T, Ziegler DS, Gottardo N, Dholaria H, Doughman R, Benesch M, Drissi R, Nazarian J, Jabado N, Boddaert N, Varlet P, Giraud G, Castel D, Puget S, Jones C, Hulleman E, Modena P, Giagnacovo M, Antonelli M, Pietsch T, Gielen GH, Jones DTW, Sturm D, Pfister SM, Gerber NU, Grotzer MA, Pfaff E, von Bueren AO, Hargrave D, Solanki GA, Jadrijevic Cvrlje F, Kaspers GJL, Vandertop WP, Grill J, Bailey S, Biassoni V, Massimino M, Calmon R, Sanchez E, Bison B, Warmuth-Metz M, Leach J, Jones B, van Vuurden DG, Kramm CM, Fouladi M.

J Clin Oncol. 2018 Jul 1;36(19):1963-1972. doi: 10.1200/JCO.2017.75.9308. Epub 2018 May 10.

42.

Health-care providers' perspectives on health-insurance access, waiving procedures, and hospital detention practices in Kenya.

Mostert S, Njuguna F, van der Burgt RHM, Musimbi J, Langat S, Skiles J, Seijffert A, Sitaresmi MN, Vik TA, van de Ven PM, Kaspers GJL.

Pediatr Blood Cancer. 2018 Aug;65(8):e27221. doi: 10.1002/pbc.27221. Epub 2018 May 9.

PMID:
29741267
43.

Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group.

van der Sluis IM, de Groot-Kruseman H, Te Loo M, Tissing WJE, van den Bos C, Kaspers GJL, Bierings M, Kollen WJW, König T, Pichlmeier U, Kühnel HJ, Pieters R.

Pediatr Blood Cancer. 2018 Aug;65(8):e27083. doi: 10.1002/pbc.27083. Epub 2018 May 4.

PMID:
29727043
44.

An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia.

Kaspers GJL, Niewerth D, Wilhelm BAJ, Scholte-van Houtem P, Lopez-Yurda M, Berkhof J, Cloos J, de Haas V, Mathôt RA, Attarbaschi A, Baruchel A, de Bont ES, Fagioli F, Rössig C, Klingebiel T, De Moerloose B, Nelken B, Palumbo G, Reinhardt D, Rohrlich PS, Simon P, von Stackelberg A, Zwaan CM.

Br J Haematol. 2018 May;181(4):523-527. doi: 10.1111/bjh.15233. Epub 2018 Apr 20.

PMID:
29676440
45.

RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML.

Cucchi DGJ, Denys B, Kaspers GJL, Janssen JJWM, Ossenkoppele GJ, de Haas V, Zwaan CM, van den Heuvel-Eibrink MM, Philippé J, Csikós T, Kwidama Z, de Moerloose B, de Bont ESJM, Lissenberg-Witte BI, Zweegman S, Verwer F, Vandepoele K, Schuurhuis GJ, Sonneveld E, Cloos J.

Blood. 2018 May 31;131(22):2485-2489. doi: 10.1182/blood-2017-12-819508. Epub 2018 Apr 18.

PMID:
29669779
46.

Validation of the PROMIS Sleep Disturbance and Sleep-Related Impairment item banks in Dutch adolescents.

van Kooten JAMC, van Litsenburg RRL, Yoder WR, Kaspers GJL, Terwee CB.

Qual Life Res. 2018 Jul;27(7):1911-1920. doi: 10.1007/s11136-018-1856-x. Epub 2018 Apr 16.

47.

Influence of health insurance status on paediatric non-Hodgkin's lymphoma treatment in Kenya.

Martijn HA, Njuguna F, Olbara G, Langat S, Skiles J, Martin S, Vik T, van de Ven PM, Kaspers GJ, Mostert S.

BMJ Paediatr Open. 2017 Aug 11;1(1):e000149. doi: 10.1136/bmjpo-2017-000149. eCollection 2017.

48.

Reproductive intentions and use of reproductive health care among female survivors of childhood cancer.

van Dijk M, van den Berg MH, Overbeek A, Lambalk CB, van den Heuvel-Eibrink MM, Tissing WJ, Kremer LC, van der Pal HJ, Loonen JJ, Versluys B, Bresters D, Kaspers GJL, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER-VEVO study group.

Hum Reprod. 2018 Jun 1;33(6):1167-1174. doi: 10.1093/humrep/dey058.

PMID:
29617794
49.

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia.

Cloos J, Harris JR, Janssen JJWM, Kelder A, Huang F, Sijm G, Vonk M, Snel AN, Scheick JR, Scholten WJ, Carbaat-Ham J, Veldhuizen D, Hanekamp D, Oussoren-Brockhoff YJM, Kaspers GJL, Schuurhuis GJ, Sasser AK, Ossenkoppele G.

J Vis Exp. 2018 Mar 5;(133). doi: 10.3791/56386.

50.

Clinical challenges in de novo pediatric acute myeloid leukemia.

Klein K, de Haas V, Kaspers GJL.

Expert Rev Anticancer Ther. 2018 Mar;18(3):277-293. doi: 10.1080/14737140.2018.1428091. Epub 2018 Jan 20. Review.

PMID:
29338495

Supplemental Content

Loading ...
Support Center